Search Results - Oplustilova, Lenka

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment

    Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment by Oplustilova, Lenka, Wolanin, Kamila, Mistrik, Martin, Korinkova, Gabriela, Simkova, Dana, Bouchal, Jan, Lenobel, Rene, Bartkova, Jirina, Lau, Alan, O'Connor, Mark J., Lukas, Jiri, Bartek, Jiri

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Aberrations of the MRE11–RAD50–NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene

    Aberrations of the MRE11–RAD50–NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene by Bartkova, Jirina, Tommiska, Johanna, Oplustilova, Lenka, Aaltonen, Kirsimari, Tamminen, Anitta, Heikkinen, Tuomas, Mistrik, Martin, Aittomäki, Kristiina, Blomqvist, Carl, Heikkilä, Päivi, Lukas, Jiri, Nevanlinna, Heli, Bartek, Jiri

    Published in Molecular oncology
    Request full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Low-dose DNA damage and replication stress responses quantified by optimized automated single-cell image analysis

    Low-dose DNA damage and replication stress responses quantified by optimized automated single-cell image analysis by Mistrik, Martin, Oplustilova, Lenka, Lukas, Jiri, Bartek, Jiri

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Abstract 4719: Targeting interdependent signaling pathways to increase the durability and magnitude of response: promising combination therapy with dual mTORC1/2 inhibitors and CDK4/6 inhibitors

    Abstract 4719: Targeting interdependent signaling pathways to increase the durability and magnitude of response: promising combination therapy with dual mTORC1/2 inhibitors and CDK... by Crafter, Claire, Curwen, Jon, Delpuech, Oona, Oplustilova, Lenka, Green, Stephen, Brown, Henry, Trigwell, Cath, Cosulich, Sabina

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Abstract 4420: Generating preclinical models to assess bone marrow toxicity induced by the PARP inhibitor olaparib in combination with chemotherapy

    Abstract 4420: Generating preclinical models to assess bone marrow toxicity induced by the PARP inhibitor olaparib in combination with chemotherapy by O'Connor, Mark J., Mason, Helen, Horner, Steve, Slater, Ian, Lau, Alan, Cadogan, Elaine, Oplustilova, Lenka

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Correction to Oplustilova L, et al. Cell Cycle Volume 11, Issue 20; pp. 3837-50

    Correction to Oplustilova L, et al. Cell Cycle Volume 11, Issue 20; pp. 3837-50 by Oplustilova, Lenka, Wolanin, Kamila, Mistrik, Martin, Korinkova, Gabriela, Simkova, Dana, Bouchal, Jan, Lenobel, Rene, Bartkova, Jirina, Lau, Alan, O'Connor, Mark J., Lukas, Jiri, Bartek, Jiri

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Abstract 2398: Activity of the PARP inhibitor olaparib in ATM-deficient gastric cancer: from preclinical models to the clinic

    Abstract 2398: Activity of the PARP inhibitor olaparib in ATM-deficient gastric cancer: from preclinical models to the clinic by Hodgson, Darren, Mason, Helen, Oplustilova, Lenka, Harbron, Chris, Yin, Xiaolu, Im, Seock-Ah, Jones, Helen, Zhongwu, Lai, Dougherty, Brian, McLoughlin, Matthew, Bradford, James, Dickinson, Andrew, Fielding, Anitra, Robertson, Jane, Kim, Woo-Ho, Womack, Chris, Gu, Yi, Bang, Yung-Jue, Lau, Alan, Barrett, J. Carl, O'Connor, Mark J.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: